208 results
SC TO-T
EX-99
PFNX
Pfenex Inc.
31 Aug 20
Third party tender offer statement
8:46am
Company, LLC
Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, New York 11219
By mail:
American Stock Transfer & Trust … Company, LLC Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, New York 11219
For assistance
Call Toll-Free (877) 248
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
. Dr. Cochran is the Shriram Chair of the Department of Bioengineering at Stanford University, where she also is a professor of bioengineering … in the Department of biological engineering. She holds a B.S. in biochemistry from the University of Delaware. She has been recognized with numerous awards
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Jun 11
Regulation FD Disclosure
12:00am
, Department of Internal
Medicine, University of Genoa, Genoa, Italy; 3. Department of Medicine, Gastroenterology and Hepatology, Post Graduate Medical … Institute, and Lahore
General Hospital, Lahore, Pakistan; 4. Department of Gastroenterology, Services Hospital Lahore, Services Institute of Medical
8-K
EX-99.1
84xbknpnya
23 Jun 11
Regulation FD Disclosure
12:00am
8-K
EX-10.2
i6k29m
24 Dec 08
Ligand Completes Pharmacopeia Acquisition
12:00am
8-K
EX-99.1
g3ptf0fkax xybr0b5
24 Jun 10
Regulation FD Disclosure
12:00am
424B3
70cviw2oyjnj9kg
14 Nov 06
Prospectus supplement
12:00am
SC TO-T
EX-99
yed5c17c
31 Aug 20
Third party tender offer statement
8:46am
8-K
k6r6bm 2d
6 Sep 05
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
424B3
ihjr3hwq8pyifr
15 May 06
Prospectus supplement
12:00am
8-K
7zo68oy4itws9
11 Jul 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10
3ssni jxijduezx2
22 Aug 07
Departure of Directors or Principal Officers
12:00am